FdaApplication
NDA 220200
Identifiers
- fda_app_no: NDA220200
Properties
| Property | Value |
|---|---|
| applicant_name | AVYXA HOLDINGS LLC |
| application_type | NDA |
| approval_date | 2026-02-13 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AVOPEF | ETOPOSIDE | 500MG/25ML (20MG/ML) | SOLUTION;INTRAVENOUS |
| AVOPEF | ETOPOSIDE | 100MG/5ML (20MG/ML) | SOLUTION;INTRAVENOUS |
2 products